Ohio’s life sciences ecosystem is no longer flying under the radar — it’s taking flight. Over the past few years, the Buckeye State has evolved from a quiet contributor into a coordinated hub for biotech, medtech, and biomanufacturing innovation.
In a recent BioBuzz podcast, Chris Frew spoke with Eddie Pauline, President & CEO of Ohio Life Sciences (OLS), about how the state’s assets, people, and policies are all uniting under a shared vision of growth.
“Ohio’s got a long history — probably a four-decade history — of investing in building out this ecosystem,” Pauline shared during our recent What’s the Buzz? interview. “We’re finally realizing the return on those historic investments and are on the cusp of cementing ourselves as a true hub in the U.S.”
That foundation includes an impressive end-to-end life sciences value chain — from world-renowned research and validation to manufacturing and distribution. With institutions like Cleveland Clinic, Ohio State University, Cincinnati Children’s, and Battelle, innovation starts early and often in Ohio. Companies such as Medpace, CTI, and Charles River support the validation and development process, while manufacturers like Amgen and Hikma have established major operations that translate ideas into real-world products. Global distributors like Cardinal Health and McKesson complete the chain, creating a fully integrated ecosystem rare in most states.
Still, Pauline acknowledges that Ohio has more work to do in the “middle” — scaling and manufacturing. “We’re real strong in discovery and distribution,” he said. “We have some room to grow in manufacturing and R&D expansion. We’re actively working to recruit those companies and make sure new technologies coming out of our institutions can grow right here in Ohio — without having to run to the coasts for capital or talent.”
A cornerstone of that effort is The Ohio Discovery Corridor, a partnership between OLS and JobsOhio, the state’s private workforce development organization. The initiative connects the assets and institutions along the I-71 corridor — Cleveland, Columbus, and Cincinnati — under one unified brand, creating what Pauline calls a “more intentional collaboration” across regions. “If you come to Ohio,” he said, “you’ll have easy access to world-renowned institutions and companies in a pretty efficient way.”
Those collaborations have already paid off. JobsOhio invested $100 million in the state’s three major innovation districts, each anchored by powerhouse institutions like Case Western, Cleveland Clinic, Ohio State, and Nationwide Children’s Hospital. These districts have become hotbeds of activity where researchers, entrepreneurs, and investors collide — literally and figuratively — to turn discoveries into scalable businesses.
But perhaps Ohio’s most strategic investment lies in workforce development. Pauline emphasizes that for Ohio to sustain its growth, it must continually develop new technical talent. “We’ve accommodated the needs of our current clients,” he said, “but in order to stay competitive, we knew we needed to continue investing in training biotechnicians.” That realization led to the creation of a $30 million biomanufacturing training facility, built in partnership with JobsOhio and administered by OLS.
The state is also seeding grassroots education through programs like BioPathways, which introduces K–12 students to careers in life sciences, and biotech bootcamps at community colleges, providing quick, practical training for adults pivoting into the industry. “It’s been transformational,” Pauline noted. “In eight to twelve weeks, participants learn the basics of GMP manufacturing and are ready to go to work at companies like Amgen, earning $25 to $30 an hour.”
These programs aren’t just helping fill jobs — they’re building awareness. “I’ve been surprised by how much work it takes to remind people that we already have a robust life sciences industry here,” Pauline admitted. “A decade ago, we didn’t have the density of opportunities we do now. But today, if someone moves here for a role and it doesn’t work out, there are other life science employers ready to hire. That wasn’t the case five years ago.”
That kind of ecosystem density has made Ohio an increasingly attractive destination for both talent and companies. Biotech leaders relocating from traditional coastal hubs are often surprised by what they find. “They come here hesitantly,” Pauline said, “but they quickly turn into advocates. They go back to their networks saying, ‘Ohio’s been great — I can afford a house, my commute is easy, and the quality of life is fantastic.’”
This growing reputation has fueled what Pauline proudly refers to as Team Ohio — a collective effort between OLS, JobsOhio, and local economic development groups. One new initiative, Life Science Ready Communities, helps cities inventory their assets and prepare for biotech growth, similar to Massachusetts’ successful BioReady program. “We have more people than ever wanting to win in this industry,” Pauline said. “If you’re considering Ohio, you’ll find that you’re going to have a lot of support.”
Looking ahead, Pauline envisions Ohio as a state that no longer surprises people for its life science credentials. “In five years, I want to have fewer ‘I didn’t know that was in Ohio’ conversations,” he said. “We want people to think of Ohio when they think about biotech. Between our assets, our workforce, and the partnerships we’ve built, there’s no reason we shouldn’t be one of the country’s top life science hubs.”
With its deep roots, strategic vision, and growing community of believers, Ohio is well on its way. As Pauline put it best: “The table’s set — and the future is ours to build.”
Watch our full interview and subscribe to hear more interviews with life science ecosystem builders.
